Transocean Ltd vs Relay Therapeutics Inc. Common Stock — how do they compare? Transocean Ltd trades at $5.59 (market cap $6.19B), while Relay Therapeutics Inc. Common Stock trades at $17.46 (market cap $3.82B). The key difference: Transocean Ltd is the larger of the two by market cap, and Relay Therapeutics Inc. Common Stock is trading nearer its 52-week high, Transocean Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Transocean Ltd for 18 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| RIG | RLAY | |
|---|---|---|
Market Cap | $6.19B | $3.82B |
Volume | 30,564,415 | 4,332,079 |
Sector | Energy | Health |
52-Week High | $7.58 | $20.75 |
52-Week Low | $3.08 | $6.03 |
Typical Hold Time | 18 Days | 0 Days |
Enterprise Value | $10.80B | $2.93B |
Signals from Pluang's Aura AI — not financial advice
Transocean (RIG) trades at $5.39, down slightly by 0.19%, with a bearish technical signal from moving averages. The company reported a net loss of $2.92 billion in 2025, though revenue remains stable near $4 billion. Recent news highlights the $5.8 billion Valaris acquisition, approved by the DOJ, and new contracts like the $80 million deal for the Deepwater Conqueror, providing operational momentum amid a challenging profitability landscape.
The outlook is speculative, hinging on successful deleveraging and integration of the Valaris deal to improve cash flow. Key risks include high debt levels, execution challenges, and persistent negative margins. Analyst sentiment is mixed, with a 39% buy rating, reflecting cautious optimism tied to offshore cycle strength and debt reduction progress.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Transocean Ltd. is a leading international provider of offshore contract drilling services for oil and gas wells. The company operates one of the world's most versatile fleets of mobile offshore drilling units, including ultra-deepwater drillships and harsh environment semi-submersibles. RIG's services are essential to energy exploration and production companies seeking to access deepwater and challenging reserves globally.
Read more on RIG →Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →